Navamedic ASA (OSL:NAVA)

Norway · Delayed Price · Currency is NOK

20.80

+0.85 (4.26%)

Mar 13, 2026, 2:57 PM CET

Revenue by Segment

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharma and Healthcare Division	565.36M	531.44M	512.00M	382.14M	278.44M
Pharma and Healthcare Division Growth	6.38%	3.80%	33.98%	37.24%	32.67%
Total	565.36M	531.44M	512.00M	382.14M	278.44M
Total Growth	6.38%	3.80%	33.98%	37.24%	32.67%

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Norway	201.65M	214.12M	198.89M	138.05M
Norway Growth	-5.83%	7.66%	44.07%	114.62%
Sweden	185.54M	158.92M	96.74M	59.88M
Sweden Growth	16.75%	64.27%	61.57%	10.52%
Denmark	38.86M	38.07M	28.15M	27.61M
Denmark Growth	2.09%	35.25%	1.94%	-18.53%
Finland	36.24M	27.71M	17.95M	13.85M
Finland Growth	30.79%	54.35%	29.64%	-15.28%
The Netherlands	34.75M	54.01M	26.37M	-
The Netherlands Growth	-35.66%	104.85%	-	-
Other countries	34.40M	19.18M	14.05M	39.06M
Other countries Growth	79.39%	36.53%	-64.03%	-5.07%
Total	531.44M	512.00M	382.14M	278.44M
Total Growth	3.80%	33.98%	37.24%	32.67%

Source: S&P Global Market Intelligence.